Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 16Gastrointestinal 5CNS 4Breast 4Tumor-Agnostic 3Sarcoma 3Endocrine 3Head & Neck 2Dermatologic 2Thoracic 1Plasma cell 1Other hematologic neoplasm 1NET 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Neuroendocrine Tumors 8Neoplasms 4Thyroid Neoplasms 3Thyroid Cancer, Papillary 3Pancreatic Neoplasms 3Neoplasm Metastasis 3Carcinoid Tumor 3Adenoma, Islet Cell 3Adenocarcinoma, Follicular 3Paraganglioma 2Carcinoma, Medullary 2Carcinoma 2Adenoma 2Pheochromocytoma 1Pancreatic Neuroendocrine Tumour Metastatic 1Pancreatic Neuroendocrine Tumors 1Pancreatic Diseases 1Neuroectodermal Tumors, Primitive 1Neuroectodermal Tumors 1Neoplasms, Nerve Tissue 1Neoplasms, Glandular and Epithelial 1Neoplasms, Germ Cell and Embryonal 1Neoplasms by Site 1Neoplasms by Histologic Type 1Metastatic Digestive System Neuroendocrine Tumor G1 1Gastro-enteropancreatic neuroendocrine tumor 1Endocrine System Diseases 1Endocrine Gland Neoplasms 1Digestive System Neoplasms 1Digestive System Diseases 1

Interventions

Doxorubicin 4Sunitinib 3Radiosurgery 3Everolimus 3pembrolizumab 2exemestane 2Tamoxifen 2Specimen Handling 2Octreotide 2Magnetic Resonance Spectroscopy 2Fulvestrant 2Filgrastim 2Biopsy 2Bevacizumab 23-Iodobenzylguanidine 2tislelizumab 1surufatinib 1romidepsin 1regorafenib 1penpulimab 1pasireotide 1mercaptoundecahydrododecaborate 1lutetium Lu 177 dotatate 1lanreotide 1ganitumab 1folfirinox 1fludarabine phosphate 1epothilone B 1entrectinib 1dostarlimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Neoplasm Metastasis × Sunitinib × Endocrine × Clear all
NCT00843037 2024-10-17

SNIPP

University Health Network, Toronto

Phase 2 Completed
25 enrolled 19 charts
CNSEndocrine

Neoplasm Metastasis, Paraganglioma, Pheochromocytoma

NCT01731925 2017-01-31

SUNLAND

GERCOR - Multidisciplinary Oncology Cooperative Group

Phase 2 Unknown
44 enrolled
Endocrine

Carcinoid Tumor, Neoplasm Metastasis

NCT00434109 2012-09-14

Phase II Study of Sunitinib Malate Following Hepatic Artery Embolization

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Completed
39 enrolled 11 charts
EndocrineNET

Carcinoid Tumor, Adenoma, Islet Cell, Neoplasm Metastasis, Neoplasms, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡